Table 1 Baseline clinical and demographic characteristics
All patients (n = 680) | Normal glucose (n = 344) | Impaired fasting glucose (n = 132) | Diabetes mellitus (n = 204) | P value | ||
|---|---|---|---|---|---|---|
Age | 65,4 ± 14 | 62,5 ± 15,6 | 68,9 ± 11,9 | 67,8 ± 11,3 | 0,328 | |
Male | 358(52,6) | 173(50,3) | 66(50) | 119(58,3) | 0,151 | |
Body mass index | 28,3 ± 12,2 | 27,6 ± 5,5 | 27,4 ± 3,8 | 30,2 ± 20,8 | 0,146 | |
ASA status | 1 | 117(17,2) | 88(25,6) | 18(13,8) | 0 | < 0,001 |
2 | 344(50,6) | 182(52,9) | 76(57,6) | 97(47,5) | ||
3 | 166(24,4) | 54(15,7) | 27(20,5) | 85(41,7) | ||
4 | 53(7,8) | 20(5,8) | 11(8,3) | 22(10,8) | ||
Hypertension | 375(55,1) | 152(44,2) | 79(59,8) | 144(70,6) | < 0,001 | |
Current smoking | 100(14,7) | 51(14,8) | 17(12,9) | 32(15,7) | 0,66 | |
Coronary artery disease | 182(26,8) | 64(18,6) | 29(22) | 89(43,6) | < 0,001 | |
Heart failure | 69(10,1) | 20(5,8) | 16(12,1) | 33(16,2) | < 0,001 | |
History of CVA | 65(9,6) | 24(7) | 16(12,1) | 25(12,3) | 0,068 | |
Atrial fibrillation | 82(12,1) | 43(12,5) | 13(9,8) | 26(12,7) | 0,683 | |
NYHA functional class | 1 | 426(62,6) | 233(67,7) | 85(64,4) | 108(52,9) | < 0,001 |
2 | 235(34,6) | 108(31,4) | 45(34,1) | 82(40,2) | ||
3 | 18(2,6) | 3(0,9) | 2(1,5) | 13(6,4) | ||
4 | 1(0,1) | 0(0) | 0(0) | 1(0,5) | ||
Revised cardiac risk index | 0 | 95(14) | 63(18,3) | 19(14,4) | 13(6,4) | < 0,001 |
1 | 313(46) | 187(54,4) | 57(43,2) | 69(33,8) | ||
2 | 195(28,7) | 75(21,8) | 45(34,1) | 75(36,8) | ||
3 | 70(10,3) | 19(5,5) | 10(7,6) | 41(20,1) | ||
4 | 7(1) | 0(0) | 1(0,8) | 6(2,9) |